Human thyrotropin receptor compositions and use thereof

Compositions a base de recepteur de la thyrotropine humaine

Patent Citations (0)

    Publication numberPublication dateAssigneeTitle

NO-Patent Citations (2)

    Title
    None
    See also references of EP 0959896A4

Cited By (24)

    Publication numberPublication dateAssigneeTitle
    EP-2997039-A4November 30, 2016Siemens Healthcare Diagnostics IncStabilized liquid formulations containing receptors
    JP-2011026330-AFebruary 10, 2011Mannkind Corp, マンカインド コーポレイションペプチドおよびタンパク質の薬学的因子の精製および安定化
    JP-2013049684-AMarch 14, 2013Mannkind Corp, マンカインド コーポレイションPurification and stabilization of peptide and protein pharmaceutical agents
    US-2016084847-A1March 24, 2016Siemens Healthcare Diagnostics Inc.Stabilized liquid formulations containing receptors
    US-8889099-B2November 18, 2014Mannkind CorporationMethods and compositions for delivering peptides
    US-9220687-B2December 29, 2015Mannkind CorporationSubstituted diketopiperazine analogs for use as drug delivery agents
    US-9283193-B2March 15, 2016Mannkind CorporationMethod of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
    US-9346766-B2May 24, 2016Mannkind CorporationCatalysis of diketopiperazine synthesis
    US-9364436-B2June 14, 2016Mannkind CorporationHigh capacity diketopiperazine microparticles and methods
    US-9446001-B2September 20, 2016Mannkind CorporationIncreasing drug affinity for crystalline microparticle surfaces
    US-9610351-B2April 04, 2017Mannkind Corporation, Torrey Pines Institute For Molecular StudiesMethods and compositions for treating pain
    US-9630930-B2April 25, 2017Mannkind CorporationDiketopiperazine microparticles with defined specific surface areas
    US-9655850-B2May 23, 2017Mannkind CorporationSubstituted diketopiperazine analogs for use as drug delivery agents
    US-9662461-B2May 30, 2017Mannkind CorporationDry powder drug delivery system and methods
    US-9675674-B2June 13, 2017Mannkind CorporationDiketopiperazine salts for drug delivery and related methods
    US-9700690-B2July 11, 2017Mannkind CorporationInhalation apparatus
    US-9706944-B2July 18, 2017Mannkind CorporationApparatus and method for simulating inhalation efforts
    US-9717689-B2August 01, 2017Mannkind CorporationMethod of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
    US-9796688-B2October 24, 2017Mannkind CorporationCatalysis of diketopiperazine synthesis
    US-9801925-B2October 31, 2017Mannkind CorporationPotentiation of glucose elimination
    US-9802012-B2October 31, 2017Mannkind CorporationDry powder drug delivery system and methods
    WO-0234042-A2May 02, 2002Deltagen, Inc.Knockout mice thyroid stimulating hormone receptor (tsh-r) gene
    WO-0234042-A3September 04, 2003Keith D Allen, Deltagen IncSouris transgeniques contenant des disruptions geniques du recepteur de l'hormone de stimulation thyroidienne (tch-r)
    WO-2014186402-A1November 20, 2014Siemens Healthcare Diagnostics Inc.Stabilized liquid formulations containing receptors